| Literature DB >> 31747863 |
Daniel F Mackay1, Tom L Clemens2, Claire E Hastie1, Mark P C Cherrie2, Chris Dibben3, Jill P Pell1.
Abstract
Background Myocardial infarction exhibits seasonal patterning, with higher amplitude at increased latitude. Epidemiological evidence suggests that sunlight is protective against cardiovascular disease, independent of ambient temperature, but ultraviolet B-mediated vitamin D production has been discounted as causal. We aimed to determine whether ultraviolet A is associated with the seasonal patterning of myocardial infarction. Methods and Results Routine hospitalization data were used to determine monthly incidence of myocardial infarction in Scotland between 2000 and 2011. Small-area-level aggregated data were obtained on ambient temperature from the Meteorological Office and ultraviolet A and ultraviolet B irradiance from NASA satellites. Autoregressive distributed lag models were run for ultraviolet A and myocardial infarction, including adjustment for ambient temperature and ultraviolet B. Monthly incidence of myocardial infarction displayed winter peaks and summer troughs superimposed on the underlying trend, with a mean amplitude of 0.31 (95% CI: 0.21, 0.41) myocardial infarctions per 100 000 population per month. Ultraviolet A exposure was inversely associated with myocardial infarction independent of ambient temperature (coefficient, -0.05; 95% CI, -0.09, -0.01; P=0.015) and ultraviolet B UVB (coefficient, -0.05; 95% CI, -0.09, -0.02; P=0.004). Conclusions Further research is required to explore whether an ultraviolet-mediated mechanism different to vitamin D, such as nitric oxide-mediated vasodilatation, may play a causal role in the seasonal and geographical patterning of myocardial infarction.Entities:
Keywords: UV radiation; environmental factors; epidemiology; myocardial infarction
Mesh:
Year: 2019 PMID: 31747863 PMCID: PMC6912961 DOI: 10.1161/JAHA.119.012551
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Crude monthly incidence of acute myocardial infarction (AMI) admissions.
Figure 2Monthly environmental exposure measurements. A, Ultraviolet A irradiance. (B) Ultraviolet B irradiance. (C) Ambient temperature.
Autoregressive Distributed Lag Model of the Associations With Incidence of Acute Myocardial Infarction Admissions of Ultraviolet A and Ultraviolet B
| Ultraviolet A | Ultraviolet B | Ultraviolet A and B | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient | 95% CI |
| Coefficient | 95% CI |
| Coefficient | 95% CI |
| |
| Fitted ADRL models | |||||||||
| Log incidence (1‐mo lag) | 0.36 | 0.22 to 0.49 | <0.001 | 0.36 | 0.23 to 0.49 | <0.001 | 0.35 | 0.20 to 0.50 | <0.001 |
| Log incidence (2‐mo lag) | 0.23 | 0.07 to 0.39 | 0.006 | 0.21 | 0.06 to 0.36 | 0.007 | ··· | ··· | ··· |
| Log ambient temperature | 0.02 | 0.0002 to 0.0400 | 0.048 | 0.02 | −0.01 to 0.02 | 0.843 | 0.01 | −0.01 to 0.03 | 0.264 |
| Log UVA | −0.01 | −0.04 to 0.02 | 0.603 | ··· | ··· | ··· | 0.01 | −0.03 to 0.04 | 0.774 |
| Log UVA (1 mo lag) | −0.05 | −0.09 to −0.01 | 0.015 | ··· | ··· | ··· | −0.05 | −0.09 to −0.02 | 0.004 |
| Log UVB | ··· | ··· | −0.01 | −0.03 to 0.001 | 0.067 | 0.002 | −0.02 to 0.02 | 0.820 | |
| Introduction of smoke‐free legislation | −0.06 | −0.11 to −0.01 | 0.010 | −0.06 | −0.12 to −0.01 | 0.031 | −0.04 | −0.09 to 0.01 | 0.107 |
| Introduction of high‐sensitivity troponin assays | 0.08 | 0.02 to 0.13 | 0.006 | 0.07 | 0.02 to 0.12 | 0.008 | 0.04 | −0.02 to 0.10 | 0.152 |
| Intercept | 0.88 | 0.52 to 1.23 | <0.001 | 0.82 | 0.47 to 1.17 | <0.001 | 1.30 | 1.00 to 1.59 | <0.001 |
Regression diagnostics: UVA: adjusted R 2, 0.76; F statistic, 46.56; P<0.001; residual Q statistic, P=0.99 at lag 13. UVB: adjusted R 2, 0.75; F statistic, 49.36; P<0.001; residual Q statistic, P=0.99 at lag 13. UVA and UVB: adjusted R 2, 0.76; F statistic, 42.78; P<0.001; Residual Q statistic, P=0.50 at lag 13. ARDL indicates autoregressive distributed lag; UVA, ultraviolet A; UVB, ultraviolet B.
Percent change in myocardial infarction incidence per unit change in exposure variable (1°C for temperature and 1 kJ/m2 for UVA/B).
Figure 3Fitted ARDL model including UVA, UVB, and ambient temperature. AMI indicates acute myocardial infarction; ARDL, autoregressive distributed lag; UVA, ultraviolet A irradiance; UVB, ultraviolet A irradiance.
Long‐Run Relationship Between Incidence of Acute Myocardial Infarction Admissions and Ultraviolet A and Ultraviolet B
| Ultraviolet A | Ultraviolet B | Ultraviolet A and B | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient | 95% CI |
| Coefficient | 95% CI |
| Coefficient | 95% CI |
| |
| Long‐run coefficients | |||||||||
| Log ambient temperature | 0.04 | −0.01 to 0.09 | 0.087 | 0.004 | −0.03 to 0.04 | 0.844 | 0.02 | −0.01 to 0.05 | 0.264 |
| Log UVA | −0.13 | −0.23 to −0.03 | 0.011 | ··· | ··· | ··· | −0.08 | −0.13 to −0.02 | 0.008 |
| Log UVB | ··· | ··· | ··· | −0.03 | −0.07 to 0.006 | 0.080 | 0.003 | −0.03 to 0.03 | 0.821 |
| Intercept | 2.09 | 1.98 to 2.20 | <0.001 | 1.92 | 1.68 to 2.16 | <0.001 | 1.99 | 1.81 to 2.18 | <0.001 |
| Error correction | −0.42 | −0.54 to −0.30 | <0.001 | −0.43 | −0.57 to −0.29 | <0.001 | −0.65 | −0.80 to −0.51 | <0.001 |
UVA indicates ultraviolet A; UVB, ultraviolet B.
Percent change in myocardial infarction incidence per unit change in exposure variable (1°C for temperature and 1 kJ/m2 for UVA/B).